Skip to main content
Clinical Trials/IRCT20230309057660N1
IRCT20230309057660N1
Recruiting
未知

The effect of cognitive-behavioral intervention in reducing fear of COVID-19 symptoms, anxiety, depression, stress and improving the quality of life in people suffering from prolonged grief disorder due to the COVID-19

Tehran University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
prolonged grief disorder.
Sponsor
Tehran University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Being within the age range of 18 to 65 years old
  • Diagnosis of COVID\-19 in an individual and the person is in the post\-treatment recovery phase and also suffers from prolonged grief disorder
  • Willingness to participate in the project and obtaining informed consent

Exclusion Criteria

  • Severe physical problems or visible organ impairment
  • Patients with major depressive disorder, psychosis, or major psychiatric disorders were not included in the study and only initial drug treatments were performed for them

Outcomes

Primary Outcomes

Not specified

Similar Trials